AOP Health signed an agreement with Leukos Biotech for the further development of a newly discovered chemical substance. With this agreement AOP Health expands the hemato-oncology research area even further and provides additional treatment options for certain leukemia patients in the longer term. Agnes Kohl, Chief Business Officer, AOP Orphan Pharmaceuticals GmbH, Member of the […]
Day: August 1, 2022
AOP Health commence la recherche d’un traitement pour la leucémie
AOP Health a signé un accord avec Leukos Biotech pour la poursuite du développement d’une substance chimique récemment découverte. Avec cet accord, AOP Health élargit encore davantage le domaine de la recherche sur l’hémato-oncologie et propose des options de traitement supplémentaires à certains patients atteints de leucémie sur le long terme. VIENNE, Autriche, 01 août […]
Zenas BioPharma Obtains IND Approval in China for Phase 1/2 Study of ZB001 for the Treatment of Thyroid Eye Disease
WALTHAM, Mass and SHANGHAI, China, July 31, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, announced that it has received approval of its Investigational New Drug (IND) application from the National Medical Products […]
Biden Confirms US Killed al-Qaida Leader Ayman al-Zawahiri
President Joe Biden said Monday that a U.S. missile strike over the weekend has killed the leader of al-Qaida, Ayman al-Zawahiri, one of the world’s most wanted terrorists.For the past decade, al-Zawahiri headed al-Qaida, the Islamist terror group that…
Ayman al-Zawahiri: From Cairo Physician to Terrorist Leader
Ayman al-Zawahiri succeeded Osama bin Laden as al-Qaida leader after years as its main organizer and strategist, but his lack of charisma and competition from rival militants Islamic State hobbled his ability to inspire spectacular attacks on the West….